BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26715139)

  • 1. Raynaud's phenomenon in limited cutaneous systemic sclerosis.
    Bonnecaze AK
    BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26715139
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic sclerosis: bilateral improvement of Raynaud's phenomenon with unilateral digital sympathectomy.
    Wasserman A; Brahn E
    Semin Arthritis Rheum; 2010 Oct; 40(2):137-46. PubMed ID: 19878974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capillary abnormalities, Raynaud's phenomenon, and systemic sclerosis in patients with localized scleroderma.
    Maricq HR
    Arch Dermatol; 1992 May; 128(5):630-2. PubMed ID: 1575525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raynaud's phenomenon and peripheral gangrene complicating scleroderma in pregnancy--diagnosis and management.
    Avrech OM; Golan A; Pansky M; Langer R; Caspi E
    Br J Obstet Gynaecol; 1992 Oct; 99(10):850-1. PubMed ID: 1419998
    [No Abstract]   [Full Text] [Related]  

  • 5. [Raynaud's syndrome--main symptom of progressive systemic sclerosis (sclerodermia)].
    Krull P; Alexander K; Fabel H; Ostertag H; Wagner HH; Deicher H
    Med Klin; 1972 Mar; 67(10):332-7. PubMed ID: 5022240
    [No Abstract]   [Full Text] [Related]  

  • 6. [Heart lesions in progressive systemic sclerosis. Intramyocardial Raynaud's phenomenon].
    Frandsen NE
    Ugeskr Laeger; 1980 May; 142(22):1423-4. PubMed ID: 7404748
    [No Abstract]   [Full Text] [Related]  

  • 7. Raynaud's phenomenon: its relevance to scleroderma.
    Belch JJ
    Ann Rheum Dis; 1991 Nov; 50 Suppl 4(Suppl 4):839-45. PubMed ID: 1750795
    [No Abstract]   [Full Text] [Related]  

  • 8. [Capillary microscopy of the nail fold in Raynaud's phenomenon. Use in the early diagnosis of scleroderma].
    Rivera Redondo J; López Bote JP; Alvaro-Gracia Alvaro JM; Sabando Suárez P; Ossorio Castellanos C
    Rev Clin Esp; 1985 Jun; 177(1):7-10. PubMed ID: 4035042
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased nailfold capillary dimensions in primary Raynaud's phenomenon and systemic sclerosis.
    Bukhari M; Herrick AL; Moore T; Manning J; Jayson MI
    Br J Rheumatol; 1996 Nov; 35(11):1127-31. PubMed ID: 8948300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse effects of stellate ganglion block on Raynaud's phenomenon associated with progressive systemic sclerosis.
    Omote K; Kawamata M; Namiki A
    Anesth Analg; 1993 Nov; 77(5):1057-60. PubMed ID: 8214705
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of Raynaud's phenomenon and digital ischemic lesions in scleroderma.
    Hummers LK; Wigley FM
    Rheum Dis Clin North Am; 2003 May; 29(2):293-313. PubMed ID: 12841296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Calcinosis, Raynaud's phenomenom, sclerodactylia and telangiectasia in progressive systemic sclerosis. Statistical analysis of contingencies].
    Mintz G
    Gac Med Mex; 1976 Jun; 107(6):525-36. PubMed ID: 976673
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of severe Raynaud's phenomenon with bosentan in a patient with systemic sclerosis.
    Dunne J; Dutz J; Shojania K; Ng B; van Eeden S
    Rheumatology (Oxford); 2006 Jul; 45(7):911-2. PubMed ID: 16531439
    [No Abstract]   [Full Text] [Related]  

  • 14. Raynaud's phenomenon and Raynaud's disease definition of Raynaud's phenomenon.
    Pratesi F; Corsi C; Deidda C; Nuti A
    Schweiz Rundsch Med Prax; 1976 Nov; 65(44):1368-70. PubMed ID: 1005332
    [No Abstract]   [Full Text] [Related]  

  • 15. Scleroderma and Raynaud's phenomenon.
    BARNETT AJ
    Clin Rep; 1959; 9():33-74. PubMed ID: 13796900
    [No Abstract]   [Full Text] [Related]  

  • 16. Serial nailfold capillary microscopy in primary Raynaud's phenomenon and scleroderma.
    ter Borg EJ; Piersma-Wichers G; Smit AJ; Kallenberg CG; Wouda AA
    Semin Arthritis Rheum; 1994 Aug; 24(1):40-7. PubMed ID: 7985036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis].
    Serri J; Legré R; Veit V; Guardia C; Gay AM
    Ann Chir Plast Esthet; 2013 Dec; 58(6):658-62. PubMed ID: 22204894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intra-arterial reserpine in Raynaud's disease and syndrome].
    Arcas Meca R; Ono Okabe S; Barroso-Moguel R; Quijano Pitman F
    Arch Inst Cardiol Mex; 1972; 42(2):260-8. PubMed ID: 5028993
    [No Abstract]   [Full Text] [Related]  

  • 19. Differences in red cell behaviour between patients with Raynaud's phenomenon and systemic sclerosis and patients with Raynaud's disease.
    Rustin MH; Kovacs IB; Sowemimo-Coker SO; Maddison PJ; Kirby JD
    Br J Dermatol; 1985 Sep; 113(3):265-72. PubMed ID: 3877518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Round fingerpad sign: an early sign of scleroderma.
    Mizutani H; Mizutani T; Okada H; Kupper TS; Shimizu M
    J Am Acad Dermatol; 1991 Jan; 24(1):67-9. PubMed ID: 1999533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.